NCT03894176View on ClinicalTrials.gov

Association of Plasma PTX3 Concentration and Outcomes of STEMI

CompletedOBSERVATIONAL
Enrollment

335

Participants

Timeline

Start Date

January 1, 2018

Primary Completion Date

August 2, 2018

Study Completion Date

September 2, 2018

Conditions
STEMICoronary; Ischemic
Interventions
OTHER

Plasma PTX3 concentration

Long pentraxin 3, thrombus burden, final TIMI flow, ST segment resolution, STEMI, primary PCI

Trial Locations (1)

11420

Indonesian Cardiovascular Research Center, Jakarta

All Listed Sponsors
lead

Indonesian Cardiovascular Research Center

OTHER

NCT03894176 - Association of Plasma PTX3 Concentration and Outcomes of STEMI | Biotech Hunter | Biotech Hunter